GTALAW wins patent case against Pfizer for client Sel-J Pharmaceuticals

March 23, 2009

Sel-J Pharmaceuticals’ Ampicillin Sulbactam (with brand name Unasan) wins the patent case filed against them by Pfizer, owner of the leading innovator brand Unasyn. The case, initially filed by Pfizer in October 2008, alleges that Unasan infringes their patent for Unasyn.

Read more
Translate »